Ellen Cheung

Biography

Dr. Ellen Cheung has over 15 years of experience with the Biotechnology and Pharmaceutical Industry. She has had the responsibilities for preclinical development and/or clinical pharmacology on project teams that had successfully brought six products to market while at Amgen and at Bayer Corporation. Dr. Cheung received her doctoral training in Medicinal/Pharmaceutical Chemistry at the University of California, San Francisco, and post-doctoral training in the Laboratory of Pharmacology and in the Laboratory of Molecular Biophysics at the National Institute of Environmental Health Sciences. She has worked at Amgen during its earlier days and contributed to the establishment and growth of the Department of Pharmacokinetics and Drug Metabolism. She was the first group leader for Amgen’s Biomathematical Modeling Team. She was Director of Preclinical Development at Bayer Corp and most recently Senior Director of Preclinical Research at InterMune, prior to devoting all of her time to consulting. Among her client list are small start-ups and mid-size biopharmaceutical companies.

Research Interest

Her areas of expertise are in preclinical pharmacokinetics/pharmacodynamics analysis and modeling; and in bioanalytics and biomarker development and validation